Community Generated Content – Barrow Hanley
The Impact of 1Q 2023 Financial Stressors on High Yield and Bank Loan Securities First quarter of 2023 presented significant volatility within the Financials sector, due to the crisis of confidence in regional banks and the subsequent demise of Silicon Valley Bank (SVB) specifically―the largest bank failure since Lehman Brothers in 2008. SVB’s failure created…
Latest
Barrow Hanley
4Q22 Review & Outlook: Diversified Large Cap Value
Learn how Barrow Hanley’s Diversified Large Cap Value strategy delivered alpha during 4Q 2022, and how it stands out amongst its peers. Mark Giambrone provides a portfolio review and market outlook here: https://www.barrowhanley.com/the-value-proposition-multimedia-insights?wchannelid=62cpn22v99&wmediaid=j51vsjmio0
Barrow Hanley
3Q 2022 Market Update: Emerging Markets
Senior Managing Director, Equity Portfolio Manager and Analyst Rand S. Wrighton Jr., CFA reviews emerging market performance during the third quarter of 2022 and provides his perspective on why emerging markets are currently compelling for investors with a two to three-year time horizon. More about Rand S. Wrighton Jr., CFA, Senior Managing Director, Equity Portfolio…
Barrow Hanley
Understand the SEC’s Proposed Climate Change Rules for Public Companies
Ross Campbell, Director of Responsible Investing, comments on the recent U.S. Securities and Exchange Commission’s proposed standardized climate risk disclosures rules for public companies – and notes the importance of these details being included in filings in order to accurately compare, assess and track over time. More About Ross Campbell, Director of Responsible Investing, Portfolio…
Latest
Verified, Tested, Trusted: How Corganics Ensures THC-Free Confidence in Clinical CBD
Corganics is redefining standards in clinical cannabinoid care with THC-free, medical-grade CBD products developed for use exclusively by healthcare professionals. Backed by Advanced Lipid Technology, FDA-registered manufacturing, and rigorous third-party testing, Corganics offers a level of trust and transparency rare in the CBD space. In a conversation with Reggie Gatewood, President of Corganics, Brooke Williams,…
Corganics’ Clinical CBD Drops: Elevating Sleep and Patient Care at Beautiphi
Corganics’ Clinical CBD Drops—THC-free, medical-grade, and developed with Advanced Lipid Technology—are designed for healthcare professionals seeking a trusted, science-backed cannabinoid solution for their patients. Manufactured in an FDA-registered facility and third-party lab tested, these drops are a cornerstone of Corganics’ clinical approach. At Beautiphi Aesthetic Boutique, founder Kelly Hermans, CRNA, has integrated the drops into…
Liz Atlee on Leadership Confidence and Letting Go of Doubt – Raise Your Hand Anyway, Even When You Feel Unsure
In this episode of Professional Quotient: Conversations That Build Equity, host Jason Winningham welcomes legal powerhouse and mentor extraordinaire Liz Atlee for an honest conversation about leadership confidence, imposter syndrome, transparency in leadership, and the importance of simply raising your hand—even when you feel unsure. Liz brings a wealth of experience navigating high-stakes legal…
Connecting the Disconnected: Inside Personify Health’s Mission to Make Personalized Care the New Standard
As healthcare costs continue to rise and patient needs become increasingly complex, personalization has emerged as a critical strategy in improving access, outcomes, and experiences. Despite 75% of surveyed Americans wishing for a more personalized healthcare experience, most health plans still offer one-size-fits-all solutions. But the shift toward personalization is more than just a…
